✦ LIBER ✦

High-dose cytosine arabinoside: response to therapy in acute leukaemia and non-Hodgkin's lymphoma

✍ Scribed by Ama Rohatiner; M. L. Slevin; H. S. Dhaliwal; J. S. Malpas; T. A. Lister

Publisher: Springer
Year: 1984
Tongue: English
Weight: 349 KB
Volume: 12
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00254596

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose cytosine arabinoside: Clinical

High-dose cytosine arabinoside: Clinical response to therapy in acute leukemia

✍ Early, A. P. ;Preisler, H. D. ;Higby, D. J. ;Brecher, M. ;Browman, G. ;McBride, 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 664 KB

High dose cytosine arabinoside (HD-AraC) was evaluated 1) as remission induction therapy for refractory acute leukemia and high risk AML, 2) as augmentation therapy for acute leukemia, and 3) as conditioning therapy prior to allogeneic bone marrow transplantation for acute leukemia. Seven of 10 pati

High-dose cytosine arabinoside in previo

High-dose cytosine arabinoside in previously treated patients with poor-prognosis non-Hodgkin's lymphoma

✍ David J. Adelstein; Hillard M. Lazarus; John D. Hines; Roger H. Herzig 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB 👁 1 views

High-dose cytosine arabinoside in relaps

High-dose cytosine arabinoside in relapsed and refractory non-Hodgkin's lymphoma. Limited role as a single agent

✍ Robert J. Soiffer; Michael A. Caligiuri; Carlo Tondini; George P. Canellos 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 520 KB

Fatal pulmonary failure complicating hig

Fatal pulmonary failure complicating high-dose cytosine arabinoside therapy in acute leukemia

✍ Borje S. Andersson; Cassian Yee; Michael J. Keating; Kenneth B. McCredie; Mario 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 620 KB

High-dose cytosine arabinoside and dauno

High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia

✍ G. Heil; P. S. Mitrou; D. Hoelzer; M. Freund; H. Link; G. Ehninger; B. Steinke; 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 746 KB

Response-oriented therapy with CHOP and

Response-oriented therapy with CHOP and VIM-Bleo in high-grade malignant non-Hodgkin's lymphomas

✍ Steinke, B. ;Kr�ger, H. U. ;Kraft, H. ;Heim, M. E. ;G�nther, E. ;Arnold, H. ;Bus 📂 Article 📅 1988 🏛 Springer-Verlag ⚖ 255 KB

Twenty four patients with high grade malignant NHL (stage II 8, stage III 4, stage IV 12 patients respectively) were treated with a response-oriented regimen: Treatment was initiated according to the CHOP-protocol. Patients achieving at least a partial remission after 2 and a complete remission (CR)